Description
Springer Diabetes and Kidney Disease 2nd Edition 2021 Softbound by Edgar V. Lerma, Vecihi Batuman
This book provides a concise yet comprehensive resource on Diabetic Kidney Disease. Similar to the previous edition, the book reviews the most up-to-date research on diabetic nephropathy, the current understanding of its pathophysiology, renal structural alterations and clinical features, and summarizes recent evidence-based clinical treatment modalities for the prevention and management of diabetic kidney disease. General clinical aspects are also covered, as well as an overview to the novel approaches being designed by leading researchers in the field.A convenient compendium for physicians involved in the care of diabetic patients with varying degrees of kidney involvement, Diabetes and Kidney Disease, 2e is also a handy resource for medical residents and students interested in the current status and future approaches to reducing the burden of diabetes and diabetic kidney disease. Historical Background of Diabetic Kidney Disease.- Review of Clinical Practice Guidelines.- Natural Course, Pathogenesis, Morphology and Genetics.- Diabetic Kidney Disease: Scope of the Problem.- Natural Course.- Pathogenesis: Hemodynamic alterations.- Pathogenesis: Structural Changes in the Kidneys in Type 1 and Type 2 Diabetes.- Diabetes in Children and Adolescents.- Clinical Presentation and Associated Conditions.- Screening, Early Diagnosis, Genetic markers and Predictors of Progression.- Atypical Presentations.- Albuminuria and Proteinuria.- Hypertension and Diabetes.- Obesity and Metabolic Syndrome.- Anemia and Diabetes.- Carvdiovascular Disease and Diabetes.- Dyslipidemia and Diabetes.- Bone Disease and Diabetes.- Diabetic Retinopathy.- Pregnancy and Diabetes.- Kidney Transplantation and Kidney Pancreas Transplantation.- Diabetic Kidney Disease and Covid-19.- Treatment and Prognosis.- Glycemic Control.- Computerized Clinical Decision Support.- Antihypertensive therapies.- Metformin.- Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors.- Glucagon-like Peptide-1 Receptor Agonists (GLP1-RA).- Dipeptidyl Peptidase-4 (DPP4) Inhibitors.- Novel Treatments and the Future of DKD: What is on the Horizon?.- Putting it All Together: Practical Approach to the Patient with Diabetic Kidney Disease.